MTM Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Buy
+7,506
New +$200K 0.09% 91
2026
Q2
– Sell
-7,701
Closed -$216K – 97
2026
Q1
$216K Buy
+7,701
New +$205K 0.1% 85
2025
Q4
– Sell
-8,225
Closed -$210K – 90
2025
Q3
$210K Sell
8,225
-597
-7% -$14.7K 0.1% 82
2025
Q2
$214K Hold
8,822
– – 0.12% 75
2025
Q1
$224K Hold
8,822
– – 0.13% 70
2024
Q4
$234K Hold
8,822
– – 0.14% 70
2024
Q3
$255K Sell
8,822
-103
-1% -$3K 0.16% 67
2024
Q2
$250K Hold
8,925
– – 0.16% 60
2024
Q1
$248K Sell
8,925
-293
-3% -$8.13K 0.16% 58
2023
Q4
$265K Sell
9,218
-975
-10% -$29.5K 0.19% 47
2023
Q3
$338K Buy
10,193
+200
+2% +$7.07K 0.28% 38
2023
Q2
$367K Hold
9,993
– – 0.31% 38
2023
Q1
$408K Hold
9,993
– – 0.36% 32
2022
Q4
$512K Hold
9,993
– – 0.45% 30
2022
Q3
$437K Hold
9,993
– – 0.4% 32
2022
Q2
$524K Hold
9,993
– – 0.46% 31
2022
Q1
$517K Buy
+9,993
New +$518K 0.54% 30

Other funds holding PFE

MTM Financial Group's PFE Position: Q3 2026 in Review

MTM Financial Group opened a new position in Pfizer (PFE) in Q3 2026: 7,506 shares worth $214K. The stake represents 0.09% of the portfolio and ranks #91 among its holdings. This is a return to the name: MTM Financial Group previously reported a position in PFE as recently as Q1 2026.

MTM Financial Group first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $524K in Q2 2022. 2,907 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • MTM Financial Group held 7,506 shares of Pfizer worth $214K as of Q3 2026.
  • Pfizer was a new MTM Financial Group position in Q3 2026.
  • Pfizer made up 0.09% of MTM Financial Group's portfolio in Q3 2026, its #91 holding.
  • MTM Financial Group first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
  • MTM Financial Group's Pfizer position peaked at $524K in Q2 2022.
  • 2,907 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on MTM Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.